secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORDSON CORP (NDSN)
CIK:        0000072331
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0000072331-24-000169
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nordson reports Q4 sales up 4% to $744M; FY2024 record sales $2.7B; guides FY2025 adjusted EPS $9.70-$10.50
--------------------------------------------------------------------------------

- Q4 GAAP EPS $2.12 (down from $2.22 YoY); adjusted EPS $2.78 (up from $2.71 YoY).
- Full-year adjusted EPS $9.73 (down from $9.85); EBITDA record $849M (32% of sales).
- Organic sales fell 3% in Q4; Industrial Precision Solutions segment down 3% YoY.
- Atrion Medical acquisition contributed to Medical & Fluid Solutions segment sales +19%.
- Fiscal 2025 guidance: sales $2.75-$2.87B; Q1 adjusted EPS $1.95-$2.15 on seasonally weak quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72331/000007233124000169/0000072331-24-000169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72331/000007233124000169/ndsn-20241211.htm
  HTML page:      https://secwatch.observer/filing/0000072331-24-000169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer